Status:
COMPLETED
Antidepressant Treatment of AIDS Related Depression.
Lead Sponsor:
GEIGY Pharmaceuticals
Conditions:
Depression
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
To test the effectiveness treating AIDS related depression with imipramine hydrochloride. Depression syndromes are commonly associated with chronic, disabling, and fatal diseases. Due to the relentle...
Detailed Description
To test the effectiveness treating AIDS related depression with imipramine hydrochloride. Depression syndromes are commonly associated with chronic, disabling, and fatal diseases. Due to the relentle...
Eligibility Criteria
Inclusion Criteria:
- Patient must be ambulatory and relatively good health. Even if unable to work at least able to partially care care for self and not demented.
- May have been alcoholic or drug abuser 6 months previous.
- Unspecified
- CD4 Unspecified.
Exclusion Criteria:
- Non ambulatory patients or those requiring extensive help in self care are excluded.
- Non ambulatory patients or those requiring extensive help in self care are excluded.
- Current alcohol or drug abuse.
- Unspecified
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000390
Last Update
April 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Hosp - Cornell Med Ctr
New York, New York, United States, 10021